Study Reveals Reversible Damage to Brain Vessels Linked to Alzheimer's Gene
Researchers at the Icahn School of Medicine at Mount Sinai in New York have made significant strides in understanding the effects of the APOE4 gene, the strongest genetic risk factor for Alzheimer's disease. Their findings indicate that the damage caused by this gene to the brain's blood vessels may be reversible. Historically, it has been known that Alzheimer's disease leads to the deterioration of blood vessels in the brain, particularly in individuals carrying the APOE4 gene. However, the mechanisms behind this process have remained largely unclear until now. The study reveals that APOE4 contributes to the degradation of brain blood vessels by transforming pericytes—cells that typically stabilize small blood vessels—into scar-forming cells. This transformation results in thickening of the vessels and promotes the accumulation of misfolded protein clumps known as amyloid, which are the target of many current Alzheimer's treatments. The compromised blood flow to the brain due to these changes can lead to significant brain damage. The researchers discovered that blocking a protein called TGF-beta, which is involved in tissue cell activity and repair, can protect pericytes and reverse the cerebrovascular degeneration associated with APOE4 in mice. Joel Blanchard, a co-author of the study, emphasized the importance of these findings, stating, "Damage to the brain’s blood vessels is not simply a late consequence of Alzheimer’s disease; it is a biologically active process caused by APOE4 that may be reversible. These findings reveal new therapeutic targets for preserving vascular function and limiting amyloid accumulation." The research is published in two separate papers in the journals Cell and Cell Stem Cell, marking a significant advancement in the understanding of Alzheimer's disease and its underlying mechanisms. This study opens up new avenues for potential treatments aimed at reversing vascular damage in the context of Alzheimer's, which could have profound implications for future therapeutic strategies.




